Novel approaches to discovery of biomarkers in rheumatoid arthritis: comment on the article by Oswald et al.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

3 citing papers in PubMed.

1. Targeting rheumatoid arthritis: a molecular perspective on biologic therapies and clinical progress.Journal of biological engineering · 2025
   Review
2. High-resolution analyses of human sperm dynamic methylome reveal thousands of novel age-related epigenetic alterations.Clinical epigenetics · 2020
   Article
3. The mechanistic implications of gene expression studies in SSc: Insights from Systems Biology.Current treatment options in rheumatology · 2017
   Article

Corrections and comments

• Commented on by
  Reply: To PMID 25371395.2015
• Comment on
  Modular analysis of peripheral blood gene expression in rheumatoid arthritis captures reproducible gene expression changes in tumor necrosis factor responders.2015

Authors and funding

7 authors.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as